Immunological characterization of A2B adenosine receptors in human mast cells
- 1 April 2003
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 58 (4) , 461-471
- https://doi.org/10.1002/ddr.10180
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Inhibition of human mast cell activation with the novel selective adenosine A2B receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)Biochemical Pharmacology, 2001
- Netrin-1-mediated axon outgrowth and cAMP production requires interaction with adenosine A2b receptorNature, 2000
- Adenosine A2B receptors: a novel therapeutic target in asthma?Trends in Pharmacological Sciences, 1998
- Canine Mast Cell Adenosine Receptors: Cloning and Expression of the A3 Receptor and Evidence that Degranulation Is Mediated by the A2B ReceptorMolecular Pharmacology, 1997
- Tissue distribution of adenosine receptor mRNAs in the ratBritish Journal of Pharmacology, 1996
- Identification of rat serotonin 5-HT2C receptors as glycoproteins containing N-linked oligosaccharidesMolecular Brain Research, 1995
- Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma.Journal of Clinical Investigation, 1995
- Basic local alignment search toolJournal of Molecular Biology, 1990
- Studies on the receptor mediating cyclic AMP-independent enhancement by adenosine of IgE-dependent mediator release from rat mast cellsBritish Journal of Pharmacology, 1986
- Adenosine and asthmaTrends in Pharmacological Sciences, 1986